Completing the circle, TSLP has in turn been shown to activate STAT5 in malignant CTCL cells thereby promoting both their proliferation and production of IL-4 and IL-13 (Takahashi et al., 2016). Here, IL13 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.